|
The Effects of Puerarin on Insulin Resistance in Elderly Patients
with Hypertension
abstracted & translated by
Bob Flaws, Dipl. Ac. & C.H., FNAAOM, FRCHM
Keywords: Chinese medicine, Chinese herbal medicine, hypertension,
insulin resistance, puerarin
Yu Jian published an article titled, “A Study of the Effects of
Puerarin on Insulin Resistance in the Elderly with Hypertension,”
in Shan Xi Zhong Yi (Shanxi Chinese Medicine), #6, 2001,
p. 46-47.
Cohort description:
In this study, there were 32 men and 28 women, all of whom were
seen as in-patients. The youngest patient was 61 and the oldest
was 78 years of age, with a median age of 66.2 ± 5.9 years. None
of these had concomitant heart, kidney, or liver disease. These
60 patients were divided into two groups: a treatment group of 35
patients and a comparison group of 25 patients. In terms of sex,
age, and hypertension, there was no marked statistical difference
between these two groups (P , 0.05).
Treatment method:
Members of both groups continued with their original antihypertension
medicine daily life activities. In addition, the patients in the
treatment group received 500mg of Ge Gen Su Zhu She Ye (Puerarin
Injectible Fluid) in 250ml of saline solution intravenously one
time per day. Two continuous months of treatment equaled one course,
and both groups received one such course of treatment. A number
of various parameters were studied before and after treatment. These
included: blood pressure, fasting blood glucose (FBG), GhbA1c, insulin
sensitivity index (ISI), total cholesterol, triglycerides, low density
lipids (LDL), high density lipids (HDL), etc.
Treatment outcomes:
After two months, blood pressure, total cholesterol, low density
lipids, triglycerides, and indeces of blood rheology all dropped
remarkably in the treatment group from before to after treatment
(P + 0.05-0.01) and the insulin sensitivity index increased significantly
(P + 0.05). There were no significant changes in these values in
the comparison group (P , 0.05). For instance, mean ISI went from
-2.07 ± 0.45 before treatment to -1.76 ± 0.40 after treatment. This
index was measured by multiplying the FBG (mmol/L) times fasting
serum insulin (mU/L). In addition, there were significant differences
in the mean changes in all measured indeces between the treatment
and comparison groups (P + 0.05-0.01). Therefore, the conclusion
was drawn that injectible puerarin has a good effect on reducing
insulin sensitivity in elderly patients with hypertension.
Copyright © Blue Poppy Press, 2002. All rights reserved.
For more information, see Bob Flaws, Lynn Kuchinski & Robert
Casañas’s The Treatment of Diabetes Mellitus with Chinese Medicine
available from Blue Poppy Press.
|